Tissumend II Sterile Absorbable Tissue Adhesive

ArticleLast Updated March 20077 min readPeer Reviewed

Introduction

While cyanoacrylates have been used for decades to close skin wounds, their internal use has been limited because most forms of the compound are not absorbable and cause significant inflammation and foreign body reactions. Tissumend II Sterile Absorbable Tissue Adhesive (Veterinary Products Laboratories, www.vpl.com), a copolyester blend of ethyl and methoxypropyl cyanoacrylate, is now available for internal as well as external use. This compound is hydrolyzed and absorbed by tissues within 60 to 90 days after application. The adhesive is supplied in individualized, prefilled 0.2 ml pipettes that are separately packaged in nitrogen-flooded pouches. The boxed product is sterilized with gamma radiation and, when stored under refrigeration (35° to 40°F), the shelf life is one year.

IndicationsWhile cyanoacrylates are recommended for closure of declaw, tail docking, other incisional and laser surgical wounds, and for apposition of clean, debrided, traumatic wounds, absorbable versions may be useful for closing internal traumatic lacerations and surgical incisions. However, peer-reviewed reports of such uses in common internal surgical repairs are rare.1

Experimentally, methoxypropyl cyanoacrylate has been used to appose renal lacerations in rabbits.2 A rapid seal was noted at the incision site, and only single applications were needed despite presence of some hemorrhage in the area. The adhesive seemed to provide a degree of hemostasis. Application was much quicker than suturing and eliminated the risk of suture pull-through and subsequent increased parenchymal damage, which was noted with 38% of sutured repairs. On postmortem evaluation, no adhesions were seen with Tissumend II repairs, while 50% of the sutured repairs had notable adhesions. Histologically, tissue healing was similar for sutured and glued closures.2

Tissumend II Sterile Absorbable Adhesive is also effective for closure of lung lobe lacerations.1,3 When the adhesive was applied properly to experimental lung lobe incisions in cats and dogs, the wounds developed airtight seals within 8 to 11 seconds. Because hemorrhage and movement from lung expansion can dislodge the adhesive, compression of the lobe above the wound with an atraumatic clamp is recommended during application. In addition, traction longitudinally along the incision is recommended to appose the edges, although the wound may also seal without apposition if the adhesive coats the entire surface. Multiple applications may be required in some animals, particularly if the original application is too thick or is accidentally dislodged.

In cats, closure with adhesive was much easier than with suture because of the thinness of the tissues. Postoperatively, no pleural effusion was noted after 6 hours and an airtight seal was maintained for at least one week in all animals.<sup1, 3sup>

In cats, tissue reaction from the adhesive was similar to that of suture closure. In dogs, tissue adhesive closure resulted in a greater degree of tissue necrosis and foreign body reaction than suture closure.1,3 I have used Tissumend II to close a traumatic lung lobe laceration in a clinical patient; although the wound was dorsal on the lobe and bled mildly before repair, a complete seal was obtained and no postoperative pneumothorax was noted.

Clinically, animals with refractory ulcerations, descemetoceles, corneal lacerations, and lamellar keratectomy have been successfully treated with butyl cyanoacrylate application.<sup4, 5sup> However, how these studies apply to use of this specific formulation is unclear, as stated in a technical report from the manufacturer. When applied to experimentally induced corneal abrasions, Tissuemend II produced a rapid seal of the defect and caused minimal discomfort.6 Within one week after application, the stratified squamous epithelium was continuous over the surface of keratectomy sites, and by 4 weeks the stroma appeared normal.6

AdvantagesBecause Tissumend II Sterile Tissue Adhesive provides a rapid seal, surgery times may be reduced. Additionally, eventual hydrolysis of the adhesive may reduce the risk of infection and inflammatory reaction seen when nonabsorbable compounds are used.7 Exothermic reaction is limited, thus reducing potential tissue damage. Individual packaging reduces waste of the adhesive.

DisadvantagesAppropriate application of tissue adhesive requires practice, particularly when used internally. It works well if applied as a thin film; thick applications tend to contract away from tissue edges. If applied slowly or with a pipette tip contaminated by strands of glue or fibers, the adhesive will be dragged off the wound. Additionally, the adhesive adheres quickly to gloves and can therefore be accidentally dislodged if touched before dry. The adhesive will not adhere well to moist tissues. Lungs that are overinflated after application will leak, particularly if the adhesive is applied too thickly. Because the compound persists for several weeks in tissues, it is not recommended for infected wounds. It must be kept refrigerated; if exposed to temperatures above 90°F, the product may become unstable and should not be used. The adhesive may be difficult to remove from clothes or metal instruments.

Few peer-reviewed references for Tissumend II Sterile Tissue Adhesive are available; however, toxicity of cyanoacrylates in general has been widely evaluated. Toxicity depends on the specific cyanoacrylate derivative. Shorter chain derivatives (methyl- and ethyl-cyanoacrylate) such as Tissumend II are more histotoxic than longer-chain (butyl- and isobutyl-cyanoacrylate) derivatives.7 Reactions can vary from mild acute inflammation to tissue necrosis and chronic foreign body giant cell reaction.7 Toxicity can also vary between species.3

With some cyanoacrylate products, severity of reactions is not significantly different from that seen with conventional suture techniques.3,8 Clinically, tissue adhesives can provide satisfactory healing with minimal complications if used appropriately; however, use of Tissumend II Sterile Tissue Adhesive as a hemostatic agent (ie, for hepatic or splenic injury) or for certain types of internal wound closure (ie, cystotomy) have not been evaluated.<sup9, 10sup> At this time the product cannot be recommended for closure of the gastrointestinal tract because of the potential for bacterial contamination.

Economic ImpactTissue Adhesive is less expensive than most packages of suture materials. Because closure is rapid, anesthesia and surgery time is reduced, further decreasing overall costs. The absorbable nature of the compound may reduce potential inflammatory reactions seen with nonabsorbable tissue adhesives, thereby decreasing the risk of costly complications; however, proposed cost savings can only be speculated at this time.11

<supStatement of Affiliation: Dr. Tobias' research, "Comparative Efficacy of Two Surgical Closure Methods for Lung Lacerations in Dogs and Cats (Farnam Animal Health Studies FC04022 and FC04023)" was funded by Veterinary Products Laboratories, Phoenix AZ, 85013.sup>


TISSUMEND II STERILE ABSORBABLE TISSUE ADHESIVE • Karen M. Tobias

References

  1. Evaluation of Tissumend II sterile as a multipurpose absorbable tissue adhesive. Tate P, Anneaux B, Nickelson D, et al. Intl J Appl Res Vet Med 4:74-85, 2006.2. Repair of renal lacerations/injuries using sterile V-270 absorbable tissue adhesive. Anneaux BL, Tate P, Shalaby SW. Technical Report-Phoenix: Veterinary Products Laboratories, 2005.3. Farnam Animal Health study FC04022 and FC04023: Comparative efficacy of two surgical closure methods for lung lacerations in dogs and cats. Tobias KM. Technical Report-_Phoenix: Veterinary Products Laboratories, 2005.4. Cyanoacrylate tissue adhesive for treatment of refractory corneal ulceration. Bromberg NM. _Vet Ophthalmol 5:55-60, 2002.5. Clinical experience with butyl-2-cyanoacrylate adhesive in the management of canine and feline corneal disease. Watte CM, Elks R, Moore DL, et al. Vet Ophthalmol 7:319-326, 2004.6. Repair of corneal defects using sterile V-270 absorbable tissue adhesive. Anneaux BL, Tate P, Shalaby SW. Technical Report-Phoenix: Veterinary Products Laboratories, 2005.7. Histotoxicity of cyanoacrylate tissue adhesives. A comparative study. Toriumi DM, Raslan WF, Friedman M, Tardy ME. Arch Otolaryngol Head Neck Surg 116:546-550, 1990.8. Histopathological effects of ethyl 2-cyanoacrylate tissue adhesive following surgical application: An experimental study. Kaplan M, Bozkurt S, Kut MS, et al. Eur J Cardiothorac Surg 25:167-172, 2004.

  2. Effect of tissue adhesives and suture patterns on experimentally induced teat lacerations in lactating dairy cattle. Makady FM, Whitmore HL, Nelson DR, Simon J. JAVMA 198:1932-1934, 1991.10. Expanded applications for octyl-2-cyanoacrylate as a tissue adhesive. Hallock GG. Ann Plast Surg 46:185-189, 2001.11. Feline onychectomy: A retrospective study of 163 cases. Tobias KS: Vet Surg 23:274-280, 1994.

Suggested ReadingEvaluation of Tissumend II sterile as a multipurpose absorbable tissue adhesive. Tate P, Anneaux B, Nickelson D, et al. Intl J Appl Res Vet Med 4:74-85, 2006.